Jun 06, 2019 / 04:50PM GMT
Unidentified Analyst -
We have Paul Herendeen, CFO of Bausch; and we have Mark McKenna, President of Salix with us on the podium.
Questions and Answers:
Unidentified Analyst -I guess, starting off just because we like to start off with all the macro stuff, can you talk about Medicare Part D. There's been a number of proposals that have been pitched out there. Just your thoughts around Medicare Part D, your exposure to Medicare Part D within the various segments, and just your thoughts around what is being proposed?
Paul S. Herendeen - Bausch Health Companies Inc. - Executive VP & CFO
Yes. Sure. And it's Paul. We are -- first of all, we don't know exactly what's going to happen in terms of changes that we might see and how that will be implemented. Importantly, how it will be implemented. Before I even address the question, I want to be clear because people look at Bausch Health and they think of us kind of as a pharmaceutical company. We are a diversified health care company. And so, when we're talking about Med D and
Trustpilot
